Literature DB >> 32394287

Polydatin Alleviates Septic Myocardial Injury by Promoting SIRT6-Mediated Autophagy.

Xiaoyan Yuan1,2, Guo Chen1, Dongfeng Guo3, Lei Xu4, Yongfeng Gu5.   

Abstract

Sepsis is a life-threatening condition. Polydatin (PD), a small natural compound from Polygonum cuspidatum, possesses antioxidant and anti-inflammatory properties. However, the protective mechanism of PD on sepsis-induced acute myocardial damage is still unclear. The aim of this study was to investigate the effect and mechanism of action of PD on lipopolysaccharide (LPS)-induced H9c2 cells and in a rat model of sepsis, and explored the role of PD-upregulated sirtuin (SIRT)6. LPS-induced H9c2 cells were used to simulate sepsis. Cecal ligation and puncture (CLP)-induced sepsis in rats were used to verify the protective effect of PD. ELISA, western blotting, immunofluorescence, immunohistochemistry, and flow cytometry were used to study the protective mechanism of PD against septic myocardial injury. PD pretreatment suppressed LPS-induced H9c2 cell apoptosis by promotion of SIRT6-mediated autophagy. Downregulation of SIRT6 or inhibition of autophagy reversed the protective effect of PD on LPS-induced apoptosis. PD pretreatment also suppressed LPS-induced inflammatory factor expression. CLP-induced sepsis in rats showed that PD pretreatment decreased CLP-induced myocardial apoptosis and serum tumor necrosis factor-α, interleukin (IL)-1β, and IL-6 expression. 3-Methyladenine (autophagy inhibitor) pretreatment prevented the protective effect of PD on septic cardiomyopathy. SIRT6 expression was increased with PD treatment, which confirmed that PD attenuates septic cardiomyopathy by promotion of SIRT6-mediated autophagy. All these results indicate that PD has potential therapeutic effects that alleviate septic myocardial injury by promotion of SIRT6-mediated autophagy.

Entities:  

Keywords:  SIRT6; autophagy; myocardial injury; polydatin; sepsis

Mesh:

Substances:

Year:  2020        PMID: 32394287     DOI: 10.1007/s10753-019-01153-4

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  8 in total

Review 1.  Cardiomyocyte death in sepsis: Mechanisms and regulation (Review).

Authors:  Geping Zhang; Dan Dong; Xianyao Wan; Yongli Zhang
Journal:  Mol Med Rep       Date:  2022-06-15       Impact factor: 3.423

Review 2.  Emerging roles of SIRT6 in human diseases and its modulators.

Authors:  Gang Liu; Haiying Chen; Hua Liu; Wenbo Zhang; Jia Zhou
Journal:  Med Res Rev       Date:  2020-12-16       Impact factor: 12.944

3.  Roles of SIRT6 in kidney disease: a novel therapeutic target.

Authors:  Xueyan Yang; Jun Feng; Wei Liang; Zijing Zhu; Zhaowei Chen; Jijia Hu; Dingping Yang; Guohua Ding
Journal:  Cell Mol Life Sci       Date:  2021-12-24       Impact factor: 9.261

Review 4.  Research Progress on the Mechanism of Sepsis Induced Myocardial Injury.

Authors:  Cheng-Fei Bi; Jia Liu; Li-Shan Yang; Jun-Fei Zhang
Journal:  J Inflamm Res       Date:  2022-07-26

5.  Dysregulated autophagy-related genes in septic cardiomyopathy: Comprehensive bioinformatics analysis based on the human transcriptomes and experimental validation.

Authors:  Hua-Xi Zou; Bai-Quan Qiu; Ze-Yu Zhang; Tie Hu; Li Wan; Ji-Chun Liu; Huang Huang; Song-Qing Lai
Journal:  Front Cardiovasc Med       Date:  2022-08-02

Review 6.  Polydatin: Pharmacological Mechanisms, Therapeutic Targets, Biological Activities, and Health Benefits.

Authors:  Ahmad Karami; Sajad Fakhri; Leila Kooshki; Haroon Khan
Journal:  Molecules       Date:  2022-10-01       Impact factor: 4.927

7.  Polydatin Attenuates Cisplatin-Induced Acute Kidney Injury via SIRT6-Mediated Autophagy Activation.

Authors:  Zhen Li; Lu Zhou; Yiwei Du; Huirong Li; Lan Feng; Xiangnan Li; Xiao Han; Hongbao Liu
Journal:  Oxid Med Cell Longev       Date:  2022-09-16       Impact factor: 7.310

8.  Clemastine protects against sepsis-induced myocardial injury in vivo and in vitro.

Authors:  Xiaowan Wang; Di Xie; Hui Dai; Jiawei Ye; Yuqi Liu; Aihua Fei
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.